Neuren Pharmaceuticals | NEU - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Clinuvel Pharmaceuticals AUD 17.85M 9.36M 2025-12
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Genetic Signatures AUD 4.78M 680K 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
Medical Developments International AUD 5.56M 2.26M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organon & Co USD 2.5B 110M 2026-03
Paradigm Biopharmaceuticals AUD 16.6M 13.37M 2025-12
PYC Therapeutics AUD 11.01M 1.31M 2025-12
Starpharma Holdings AUD 4.61M 614K 2025-12
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Telix Pharmaceuticals AUD 231.62M 66.96M 2025-12
Viatris USD 6.81B 284M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03